Robert McWilliams - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Robert McWilliams

This paper is made freely available by the publisher.

2023 John M. Kirkwood

ORCID

, Lisa A. Kottschade, Robert R. McWilliams

ORCID

, Nikhil I. Khushalani

ORCID

, Sekwon Jang, Sigrun Hallmeyer

ORCID

, David F. McDermott

ORCID

, Hussein Tawbi

ORCID

, Min Che, Cho-Han Lee, Corey Ritchings, Trong Kim Le, Boas Park, Scott Ramsey

ORCID

Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study

Download from doi.org

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Andrea Wang-Gillam, Kian-Huat Lim, Robert McWilliams

ORCID

, Rama Suresh, Albert C. Lockhart, Amberly Brown

ORCID

, Marcus Breden, Jad I. Belle, John Herndon, Savannah J. Bogner, Katrina Pedersen, Benjamin Tan, Nicholas Boice, Abhi Acharya, Mina Abdiannia and 9 other authors

Table S2 from Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Andrea Wang-Gillam, Kian-Huat Lim, Robert McWilliams

ORCID

, Rama Suresh, Albert C. Lockhart, Amberly Brown

ORCID

, Marcus Breden, Jad I. Belle, John Herndon, Savannah J. Bogner, Katrina Pedersen, Benjamin Tan, Nicholas Boice, Abhi Acharya, Mina Abdiannia and 9 other authors

Data from Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Andrea Wang-Gillam, Kian-Huat Lim, Robert McWilliams

ORCID

, Rama Suresh, Albert C. Lockhart, Amberly Brown

ORCID

, Marcus Breden, Jad I. Belle, John Herndon, Savannah J. Bogner, Katrina Pedersen, Benjamin Tan, Nicholas Boice, Abhi Acharya, Mina Abdiannia and 9 other authors

Table S1 from Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study

Upload

This paper is made freely available by the publisher.

This paper was not found in any repository, but could be made available legally by the author.

2022 Andrea Wang-Gillam

ORCID

, Kian-Huat Lim

ORCID

, Robert McWilliams

ORCID

ORCID

, Albert C. Lockhart

ORCID

, Amberly Brown

ORCID

, Marcus Breden

ORCID

ORCID

ORCID

, Savannah J. Bogner

ORCID

, Katrina Pedersen

ORCID

ORCID

, Nicholas Boice

ORCID

ORCID

, Mina Abdiannia

ORCID

and 9 other authors

Defactinib, Pembrolizumab, and Gemcitabine in Patients with Advanced Treatment Refractory Pancreatic Cancer: A Phase I Dose Escalation and Expansion Study

Upload

This paper is made freely available by the publisher.

2021 Samuel O. Antwi

ORCID

ORCID

, William R. Bamlet

ORCID

, Margaret Meyer, Shruti Chandra, Sarah E. Fagan

ORCID

, Chunling Hu, Fergus J. Couch, Robert R. McWilliams

ORCID

ORCID

, Gloria M. Petersen

Influence of Cancer Susceptibility Gene Mutations and ABO Blood Group of Pancreatic Cancer Probands on Concomitant Risk to First-Degree Relatives

Download from aacrjournals.org

This paper is made freely available by the publisher.

Jennifer J. Gile

ORCID

ORCID

ORCID

, Joseph J. Larson

ORCID

, Kabir Mody, Zhaohui Jin

ORCID

, Joleen Hubbard

ORCID

, Thorvardur Halfdanarson

ORCID

, Steven R. Alberts

ORCID

ORCID

, Robert R. McWilliams

ORCID

ORCID

, Sumera Ilyas, Rory Smoot, Lewis Roberts

ORCID

and 4 other authors

FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2017 Robert R. McWilliams

ORCID

, Jacob B. Allred, Jessica A. Slostad, Rajini Katipamula, Roxana S. Dronca, Kandelaria M. Rumilla, Lori A. Erickson

ORCID

, Alan H. Bryce, Richard W. Joseph, Lisa A. Kottschade, David M. King, John M. Leitch, Svetomir N. Markovic

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma

Upload

This paper was not found in any repository, but could be made available legally by the author.

Robert R. McWilliams

ORCID

, Nathan R. Foster, Michelle R. Mahoney, Thomas C. Smyrk, Joseph A. Murray, Matthew M. Ames, L. Elise Horvath, Daniel J. Schneider, Timothy J. Hobday, Aminah Jatoi

ORCID

, Jeffrey P. Meyers, Matthew P. Goetz

North Central Cancer Treatment Group N0543 (Alliance): A phase 2 trial of pharmacogenetic‐based dosing of irinotecan, oxaliplatin, and capecitabine as first‐line therapy for patients with advanced small bowel adenocarcinoma

Upload

Missing publications? Search for publications with a matching author name.